Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Mapping excitatory synaptic plasticity evoked by single-dose psilocybin in micebioRxiv · 2026-08-05Music for Psilocybin Therapy and the Temporal Arc of Psychedelic ExperienceResearch Square · 2026-08-03The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01Network Pharmacology-Guided Discovery of Fungal Autophagy Modulators for Tauopathies: Structural and Proteomic EvidencebioRxiv · 2026-07-27Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping reviewPsychedelics · 2026-07-26No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory studyJournal of Psychopharmacology · 2026-07-23Probing the Functional Magnetic Resonance Imaging Response to Psilocybin in Functional Neurological Disorder (PsiFUND)ClinicalTrials.gov · 2026-07-23Psilocybin as serotonergic therapy in epilepsy: Narrative review of potentials and limitationsBritish Journal of Clinical Pharmacology · 2026-07-21Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosisFrontiers in Public Health · 2026-07-20PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical TrialClinicalTrials.gov · 2026-07-10Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.Psychopharmacology · 2026-07-01Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholdersPalliative Medicine · 2026-07-01The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.Journal of psychopharmacology (Oxford, England) · 2026-07-01Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation TheorembioRxiv · 2026-06-16Psychedelics relax predictive processing in the post-acute period by remodeling cortico-cortical feedback circuits.bioRxiv: the preprint server for biology · 2026-06-15Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-03Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland.The international journal of neuropsychopharmacology · 2026-06-02Reorganization of Human Brain Waves Across Diverse States of Consciousness.bioRxiv: the preprint server for biology · 2026-06-01Therapeutic advances in fibromyalgia: one year in review 2026.Clinical and experimental rheumatology · 2026-06-01A spatiotemporal gating hypothesis for psilocybin plasticity: reconciling the 5-HT₂A-TrkB mechanistic paradoxCell Discovery · 2026-05-29361 Effect of intravenous psilocybin on mechanical hypersensitivity in a rat model of reserpine-induced chronic centralized painJournal of clinical and translational science · 2026-05-20Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of CareCurrent Psychiatry Reports · 2026-05-14Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-07An Exploratory Pilot Study of Palliadelic Treatment to Reduce Psychological Distress in People With Pancreatobiliary and Other Advanced Gastrointestinal CancersClinicalTrials.gov · 2026-05-06Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.Journal of psychopharmacology (Oxford, England) · 2026-05-01Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)ClinicalTrials.gov · 2026-04-29Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis Volatilome.Chembiochem: a European journal of chemical biology · 2026-04-28Methamphetamine-Fentanyl Polysubstance Administration Produces Social Deficits and Corticolimbic Stress-Reward Circuit Adaptations.Research square · 2026-04-23Psychedelics and Autism Therapy: A Review of Current Research and Future Directions.Current issues in molecular biology · 2026-04-18Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionFigshare · 2026-04-09Brain-MGF: Multimodal Graph Fusion Network for EEG-FMRI Brain Connectivity Analysis Under Psilocybin2026 IEEE 23rd International Symposium on Biomedical Imaging (ISBI) · 2026-04-08Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury.Molecular psychiatry · 2026-04-01Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use DisorderClinicalTrials.gov · 2026-03-30Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.CNS & neurological disorders drug targets · 2026-03-11Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept TrialClinicalTrials.gov · 2026-03-04Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways ForwardAction Research · 2026-03-01Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010-2025): 15 Years of Progress (or Lack Thereof).CNS drugs · 2026-02-01Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Journal of affective disorders · 2026-01-15A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-01-12Behavioral effects of psychedelic and non-psychedelic serotonin 2A receptor agonist drugs in pigsNeuroscience Applied · 2026-01-01Mismatch between psilocybin-induced head-twitch behaviour and psilocin brain levels in miceNeuroscience Applied · 2026-01-01Behavioral and neuronal effects of psilocybin in miceNeuroscience Applied · 2026-01-01Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs.Journal of psychopharmacology (Oxford, England) · 2026-01-01Corrigendum to "Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder" [Neuropharmacology 279 (2025) 110648].Neuropharmacology · 2025-12-01Psilocybin vs Ketamine for Alcohol Use DisorderClinicalTrials.gov · 2025-11-28Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder.Neuropharmacology · 2025-11-15Psilocybin reduces depressive-like behavior and improves cognition in healthy aging mice via epigenetic regulation of plasticity- and immune-related genesResearch Square · 2025-11-05CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYSNeuro-Oncology · 2025-11-01The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.Pharmacology, biochemistry, and behavior · 2025-11-01Intravenous Administration of Serotonergic Psychedelics Produce Short-lasting Changes in Sleep-Wake Behavior and High Gamma Functional Connectivity in Rats.bioRxiv: the preprint server for biology · 2025-10-14Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO Study.UNC Libraries · 2025-10-09Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.Neuron · 2025-10-01Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.Psychiatry research · 2025-10-01Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesiabioRxiv · 2025-09-17Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted Therapy.Healthcare (Basel, Switzerland) · 2025-09-12Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics · 2025-07-31Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot studyJournal of Vision · 2025-07-15Psilocybin increases emotional empathy in patients with major depression.Molecular psychiatry · 2025-06-01Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.Clinical pharmacology and therapeutics · 2025-06-01Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.Expert opinion on emerging drugs · 2025-06-01Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical PopulationmedRxiv · 2025-05-29ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-05-01Improving Best Practice Indicators for Psilocybin Assisted Therapy Using a Mul-tiphase Mixed Methods Delphi StudyInternational Journal of Multiple Research Approaches · 2025-04-30Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.Palliative & supportive care · 2025-04-22Functional and structural characterization of the human indolethylamine N-methyltransferase through fluorometric, thermal and computational docking analyses.Biology direct · 2025-04-10458. Microdoses of Psilocybin Combined With Eugenol are Absorbed and Induce Unique Cerebellar Gene ExpressionBiological Psychiatry · 2025-04-09Psilocybin’s Effects on Headache Frequency are Not Related to Acute Psychedelic Effects or Measures of Mental Health: Secondary Analysis of Clinical Trials in Migraine and Cluster Headache (P7-12.001)Neurology · 2025-04-07Intravenous psilocybin induces dose-dependent changes in functional network organization in rat cortex.Translational psychiatry · 2025-03-25LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice.Pharmaceuticals (Basel, Switzerland) · 2025-03-23Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation.Journal of psychoactive drugs · 2025-03-14Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.The Journal of clinical psychiatry · 2025-03-03The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.Journal of affective disorders · 2025-03-01A systematic review of participant diversity in psychedelic-assisted psychotherapy trials.Psychiatry research · 2025-03-01Psychedelic Information TheoryProceedings of the Annual Conference of CAIS / Actes du congrès annuel de l ACSI · 2025-02-06Clinical Trial Comparing Psilocybin to Nicotine Patch for Tobacco AddictionDrug and Alcohol Dependence · 2025-02-01International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMADrug and Alcohol Dependence · 2025-02-01Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal SurveyDrug and Alcohol Dependence · 2025-02-01Source Localized Auditory Erp Sensory and Preattentive Correlates of Psilocybin-Induced Ego-Dissolution Related EffectsDrug and Alcohol Dependence · 2025-02-01Prevalence of Use of Psilocybin and MDMA in Multiple US CitiesDrug and Alcohol Dependence · 2025-02-01Oregon’s Emerging Psilocybin Services Workforce: An Environmental ScanDrug and Alcohol Dependence · 2025-02-01Lifetime Psilocybin Use and Opioid Use Disorder in Pregnant and Non-Pregnant Women of Reproductive AgeDrug and Alcohol Dependence · 2025-02-01A Systematic Review of Interventions for Demoralization in Patients with Chronic Diseases.International journal of behavioral medicine · 2025-02-01Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?Journal of Psychedelic Studies · 2025-01-21Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.Progress in neuro-psychopharmacology & biological psychiatry · 2025-01-10Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper.European psychiatry: the journal of the Association of European Psychiatrists · 2025-01-10Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.Clinical neuropharmacology · 2025-01-01Psilocybin alleviates high-glucose and high-lipid-induced skin aging in BJ5Ta fibroblasts.Biochemistry and cell biology = Biochimie et biologie cellulaire · 2025-01-01Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care.Palliative medicine reports · 2025-01-01Pattern of psychedelic substance use: a comparison between populations in Spain and South America using the Psychedelic Use Scale (PUS)Current Psychology · 2024-11-21Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuitsbioRxiv · 2024-11-07Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial.Journal of vision · 2024-11-04The molecular structure, vibrational spectra, solvation effect, non-covalent interactions investigations of psilocinSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2024-11-01Psilocybin in pharmacotherapy of obsessive-compulsive disorder.Pharmacological reports: PR · 2024-10-01What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative study.Palliative & supportive care · 2024-10-01Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry methodJournal of Chromatography A · 2024-08-01Regional Differences of Self-Reported Past-12-month Marijuana, Psilocybin, and Cocaine Use: Results From NDEWS Rapid Street Reporting 2021-2022Drug and Alcohol Dependence · 2024-07-01Prevalence of Psilocybin and Cannabis Concurrent Use During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-07-01SPONTANEOUS CHANGES IN CIGARETTE SMOKING FOLLOWING PSILOCYBIN-ASSISTED TREATMENT FOR ALCOHOL USE DISORDERDrug and Alcohol Dependence · 2024-07-01High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-07-01Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin TherapyDrug and Alcohol Dependence · 2024-07-01Physiological Effects of Psilocybin, Psilacetin, and DOI in RatsDrug and Alcohol Dependence · 2024-07-01Lifetime Depression and Psilocybin Mushroom Use in U.S. Adults, 2008-2019Drug and Alcohol Dependence · 2024-07-01Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse IndicationsDrug and Alcohol Dependence · 2024-07-01Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or PsilocybinDrug and Alcohol Dependence · 2024-07-01Developing Core Consensus Measures for Assessment of Psilocybin ServicesDrug and Alcohol Dependence · 2024-07-01Effects of psilocin and psilocybin on human 5-HT4 serotonin receptors in atrial preparations of transgenic mice and humansToxicology Letters · 2024-07-01A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use DisorderClinicalTrials.gov · 2024-06-10Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin ReceptorUNC Libraries · 2024-06-07Structural pharmacology and therapeutic potential of 5-methoxytryptamines.Nature · 2024-06-01Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.Journal of the neurological sciences · 2024-05-15Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022.Drug and alcohol dependence · 2024-05-01New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity.Cell death discovery · 2024-05-01Author Correction: Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.Scientific reports · 2024-04-23Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.Scientific reports · 2024-04-17Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways.Ageing research reviews · 2024-04-01Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.Scientific reports · 2024-03-26Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08Psilocybin induces dose-dependent changes in functional network organization in rat cortex.bioRxiv: the preprint server for biology · 2024-02-15Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey.Palliative medicine · 2024-02-01Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical studyPsyArXiv · 2024-01-11Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and NecessaryAmerican Journal of Psychiatry · 2024-01-01Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.Journal of psychopharmacology (Oxford, England) · 2024-01-01Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review.Frontiers in psychiatry · 2024-01-01Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain.Current biology: CB · 2023-12-18Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue.Life (Basel, Switzerland) · 2023-12-15Wood-loving magic mushrooms from Australia are saprotrophic invaders in the northern hemisphereAuthorea Preprints · 2023-11-17Cultivation, chemistry, and genome of.bioRxiv: the preprint server for biology · 2023-11-02Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perceptionbioRxiv · 2023-11-01Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2023-11-01Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocolEuropean Journal of Trauma & Dissociation · 2023-10-25UNRAVELLING THE ROLE OF5-HT2AR ACTIVATION IN THE LONG-LASTING BEHAVIORAL EFFECTS OF PSILOCYBINIBRO Neuroscience Reports · 2023-10-01Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2023-10-01Effects and Therapeutic Potential of Psilocybin in Alcohol DependenceClinicalTrials.gov · 2023-09-26Psychedelics: Threshold of a Therapeutic Revolution.Neuropharmacology · 2023-09-15Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2023-09-01Intravenous psilocybin administration attenuates mechanical hypersensitivity in a rat model of chronic painbioRxiv · 2023-08-28Anti-Inflammatory Effects of Serotonin Receptor and Transient Receptor Potential Channel Ligands in Human Small Intestinal Epithelial Cells.Current issues in molecular biology · 2023-08-15Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.CNS spectrums · 2023-08-01Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial.Journal of psychopharmacology (Oxford, England) · 2023-07-01Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms.Journal of psychopharmacology (Oxford, England) · 2023-07-01Psychedelics reopen the social reward learning critical periodNature · 2023-06-13Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depressionmedRxiv · 2023-06-03The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-14Default Mode Network Modulation by Psychedelics: A Systematic Review.The international journal of neuropsychopharmacology · 2023-03-22The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice.Molecules (Basel, Switzerland) · 2023-03-14Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.Neuropharmacology · 2023-03-01Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up resultsNeuroscience Applied · 2023-01-01Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective.Journal of psychopharmacology (Oxford, England) · 2023-01-01Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness.Journal of psychopharmacology (Oxford, England) · 2023-01-01Assessing potential of psilocybin for depressive disorders.Expert opinion on investigational drugs · 2023-01-01Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice.International journal of molecular sciences · 2022-12-04A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol DependenceClinicalTrials.gov · 2022-11-08Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.Neuropharmacology · 2022-11-01Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.Headache · 2022-11-01Potential Therapeutic Effects of Psilocybin: A Systematic Review.Cureus · 2022-10-01Differences across sexes on head-twitch behavior and 5-HT receptor signaling in C57BL/6J mice.Neuroscience letters · 2022-09-25Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17Natural language signatures of psilocybin microdosing.Psychopharmacology · 2022-09-01From Mushrooms to Myolysis: A Case of Rhabdo in Psilocybin-Induced Mood and Psychotic Disorder.The Journal of nervous and mental disease · 2022-08-01Brain dynamics predictive of response to psilocybin for treatment-resistant depressionbioRxiv · 2022-07-04The Neuroimaging Documentation of Psychedelic Drugs’ Effect on the Brain: dmt, lsd, Psilocybin, and Ibogaine as Examples: A Mini ReviewBrain and Neurological Disorders · 2022-06-19Production and extraction of psilocybin and psilocin from Psilocybe spp. mushroomsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-06Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DADRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-06Counselors’ attitudes toward psychedelics and their use in therapyJournal of Counseling & Development · 2022-03-19Natural language signatures of psilocybin microdosingbioRxiv · 2022-02-22The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-01-01The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-01-01Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.Frontiers in psychology · 2022-01-013,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.Frontiers in psychiatry · 2022-01-01Editorial: Old and new psychoactive substances: Pharmacology and potential applications.Frontiers in psychiatry · 2022-01-01P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot studyEuropean Neuropsychopharmacology · 2021-12-01Sociological investigations of human enhancement drugs: The case of microdosing psychedelics.The International journal on drug policy · 2021-09-01Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without.European journal of neurology · 2021-07-31Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and WellbeingPsyArXiv · 2021-05-31Complete mitochondrial genome sequence of.Mitochondrial DNA. Part B, Resources · 2021-03-18POTENCIAL USO DA PSILOCIBINA NO TRATAMENTO DA DEPRESSÃO: UMA REVISÃO / POTENTIAL USE OF PSILOCYBIN IN THE DEPRESSION TREATMENT: A REVIEWBrazilian Journal of Development · 2021-01-01Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics · 2021-01-01Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.Frontiers in pharmacology · 2021-01-01Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Well-Being.Frontiers in psychology · 2021-01-01Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in psychiatry · 2021-01-01Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor.Frontiers in immunology · 2021-01-01Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2020-02-01Matthew Oram, The Trials of Psychedelic Therapy: LSD Psychotherapy in AmericaJournal of the History of Medicine and Allied Sciences · 2020-01-13Medicinal use of psilocybin: Reducing restrictions on research and treatment.Conservative Drug Policy Reform Group · 2020-01-01P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depressionEuropean Neuropsychopharmacology · 2019-12-01Motives and Side-Effects of Microdosing With Psychedelics Among Users.The international journal of neuropsychopharmacology · 2019-07-01Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levelsNeuropsychopharmacology · 2019-06-01Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levelsNeuropsychopharmacology · 2019-06-01Increased use of illicit drugs in a Dutch cluster headache population.Cephalalgia: an international journal of headache · 2019-04-01Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.Current molecular pharmacology · 2019-01-01Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.Frontiers in psychiatry · 2019-01-01Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosersPsyArXiv · 2018-11-02Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.Neuropharmacology · 2018-11-01[Trends in Abuse of Biogenic Drugs in Parts of Germany 2007-2013].Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) · 2018-06-01